+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

PCSK9 Inhibitor Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Thumbnail Image

PCSK9 Inhibitor Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • April 2025
  • 120 Pages
  • Global
From
Lower Respiratory Tract Therapeutics Market Report 2025 - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Severe Acute Respiratory-Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Severe Acute Respiratory-Syndrome Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Geriatric Care Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Geriatric Care Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • March 2025
  • 240 Pages
  • Global
From
Epithelioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Epithelioma Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 380 Pages
  • Global
From
Metastatic Cancer Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 377 Pages
  • Global
From
Blood Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Blood Cancer Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 291 Pages
  • Global
From
Oral Cancer Treatment - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Treatment - Global Strategic Business Report

  • Report
  • February 2026
  • 279 Pages
  • Global
From
Nasopharyngeal Cancer Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Nasopharyngeal Cancer Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 288 Pages
  • Global
From
Personalized Cancer Medicines Market - Global Strategic Business Report - Product Thumbnail Image

Personalized Cancer Medicines Market - Global Strategic Business Report

  • Report
  • February 2026
  • 267 Pages
  • Global
From
Angiosarcoma Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Angiosarcoma Treatment Market - Global Strategic Business Report

  • Report
  • February 2026
  • 390 Pages
  • Global
From
Checkpoint Inhibitor Refractory Cancer Market - Global Strategic Business Report - Product Thumbnail Image

Checkpoint Inhibitor Refractory Cancer Market - Global Strategic Business Report

  • Report
  • February 2026
  • 287 Pages
  • Global
From
Skeletal Dysplasia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Skeletal Dysplasia Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Age-Related Macular Degeneration Market Size, Share and Trends Analysis Report by Product (Eylea, Lucentis), Disease (Wet AMD, Dry AMD), Distribution Channel, and Region 2024-2030 - Product Thumbnail Image

Age-Related Macular Degeneration Market Size, Share and Trends Analysis Report by Product (Eylea, Lucentis), Disease (Wet AMD, Dry AMD), Distribution Channel, and Region 2024-2030

  • Report
  • September 2024
  • 100 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors Market 2024-2028 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors Market 2024-2028

  • Report
  • October 2024
  • 136 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 129 Pages
  • Global
From
Skeletal Dysplasia Market - Product Thumbnail Image

Skeletal Dysplasia Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Viral Clearance and Viral Testing Services Market - Distribution by Scale of Operation, Method of Viral Clearance and Testing, End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Viral Clearance and Viral Testing Services Market - Distribution by Scale of Operation, Method of Viral Clearance and Testing, End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • February 2023
  • 140 Pages
  • Global
From
Autoimmune Drugs Market 2024-2028 - Product Thumbnail Image

Autoimmune Drugs Market 2024-2028

  • Report
  • July 2024
  • 185 Pages
  • Global
From
Pulmonary Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Pulmonary Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 150 Pages
  • Global
From
Loading Indicator